524322
KABRADG
Start SIP
Invest Now
Start SIP in KABRADG
Kabra Drugs live price: ₹26.1. It opened at ₹27 vs previous close ₹26; intraday high/low: ₹27/₹25. The 50 & 200 DMA stand at ₹28.69/₹23.39.
Kabra Drugs Performance
- Today's Low
- ₹25
- Today's High
- ₹27
- 52 Week Low
- ₹11
- 52 Week High
- ₹36
- Open Price₹27
- Previous Close₹26
- Volume15,752
- 50 DMA₹28.69
- 100 DMA₹27.36
- 200 DMA₹23.39
Investment Returns
- Over 1 Month -14.48%
- Over 3 Month -18.18%
- Over 6 Month + 55.26%
- Over 1 Year + 135.56%
Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!
Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.4
- PEG Ratio
- 0
- Market Cap Cr
- 62
- P/B Ratio
- 2.2
- Average True Range
- 1.81
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -1.01
- RSI
- 36.61
- MFI
- 12.03
Kabra Drugs Financials
Kabra Drugs Technicals
EMA & SMA
Current Price
₹26.10
+
0.3
(1.16%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹27.76
- 50 Day
- ₹28.69
- 100 Day
- ₹27.36
- 200 Day
- ₹23.39
Resistance and Support
25.39
- R3 27.43
- R2 26.61
- R1 26.21
- S1 24.99
- S2 24.17
- S3 23.77
Kabra Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-03-07 | Others | Inter-alia, to consider 1. Proposal for changing the name of the company. 2. Strategic expansion of business operations in Indonesia and Canada. 3. Other business matters. |
| 2026-02-13 | Quarterly Results | |
| 2025-11-28 | Others | Inter alia, To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion. |
| 2025-11-13 | Quarterly Results | |
| 2025-10-08 | Others | Inter-aliam to consider 1.Approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. Other business matters. |
Kabra Drugs F&O
About Kabra Drugs
- NSE Symbol
- KABRADG
- BSE Symbol
- 524322
- Managing Director
- Mr. N Aravind
- ISIN
- INE323K01017
Similar Stocks to Kabra Drugs
Popular Stocks
TCS Share PriceIRFC Share PriceIREDA Share PriceIRCTC Share PriceITC Share PriceWipro Share PriceSuzlon Share PriceTata Steel Share PriceYes Bank Share PriceHDFC Share PriceTata Power Share PriceInfosys Share PriceTata Motors Share PriceAdani Power Share PriceNHPC Share PriceRVNL Share PriceVedanta Share PricePaytm Share PriceLIC Share PriceBHEL Share Price
Kabra Drugs FAQs
Kabra Drugs share price is ₹26 As on 02 April, 2026 | 13:30
The Market Cap of Kabra Drugs is ₹61.9 Cr As on 02 April, 2026 | 13:30
The P/E ratio of Kabra Drugs is 14.4 As on 02 April, 2026 | 13:30
The PB ratio of Kabra Drugs is 2.2 As on 02 April, 2026 | 13:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.